Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines

Identifieur interne : 001E88 ( Main/Exploration ); précédent : 001E87; suivant : 001E89

Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines

Auteurs : William C. Gruber [États-Unis] ; Hattie P. Hinson [États-Unis] ; Kathy L. Holland [États-Unis] ; Juliette M. Thompson [États-Unis] ; George W. Reed [États-Unis] ; Peter F. Wright [États-Unis]

Source :

RBID : ISTEX:FF07394531F4CCCA10E767C1D250500F18EEB6B6

Abstract

Healthy adult subjects (n = 198) were randomized to receive bivalent cold-adapted (ca) influenza A vaccine containing 107.4TCID50each of A/Kawasaki/9/86 (H1N1) and A/Los Angeles/2/87 (H3N2) by either nose drops (ND) or large-particle aerosol (LPA). All subjects had received monovalent inactivated influenza Bvaccine intramuscularly in the previous year. Ninety percent of LPA recipients and 82% of ND recipients preferred intranasal administration to their previous experience with intramuscular vaccine. Twenty-six (27%) of 98 LPA recipients and 47 (49%) of97 ND recipients reported swallowing vaccine (P = .008). Fever was observed uncommonly (⩾5%), and incidence of respiratory symptoms was comparable between groups. Fourfold or greater hemagglutination antibody response to at least one of the influenza A vaccine viruses was significantly more frequent after LPA (64%) than ND vaccination (43%; P = .005). LPA administration of ca influenza to the nasopharynx was well tolerated, safe, and more immunogenic than ND delivery.

Url:
DOI: 10.1093/infdis/168.5.1282


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines</title>
<author>
<name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name>
</author>
<author>
<name sortKey="Hinson, Hattie P" sort="Hinson, Hattie P" uniqKey="Hinson H" first="Hattie P." last="Hinson">Hattie P. Hinson</name>
</author>
<author>
<name sortKey="Holland, Kathy L" sort="Holland, Kathy L" uniqKey="Holland K" first="Kathy L." last="Holland">Kathy L. Holland</name>
</author>
<author>
<name sortKey="Thompson, Juliette M" sort="Thompson, Juliette M" uniqKey="Thompson J" first="Juliette M." last="Thompson">Juliette M. Thompson</name>
</author>
<author>
<name sortKey="Reed, George W" sort="Reed, George W" uniqKey="Reed G" first="George W." last="Reed">George W. Reed</name>
</author>
<author>
<name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FF07394531F4CCCA10E767C1D250500F18EEB6B6</idno>
<date when="1993" year="1993">1993</date>
<idno type="doi">10.1093/infdis/168.5.1282</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-S83DKK8F-0/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001067</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001067</idno>
<idno type="wicri:Area/Istex/Curation">001067</idno>
<idno type="wicri:Area/Istex/Checkpoint">000C52</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000C52</idno>
<idno type="wicri:doubleKey">0022-1899:1993:Gruber W:comparative:trial:of</idno>
<idno type="wicri:Area/Main/Merge">001F77</idno>
<idno type="wicri:Area/Main/Curation">001E88</idno>
<idno type="wicri:Area/Main/Exploration">001E88</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines</title>
<author>
<name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Reprints or correspondence: Dr. William C. Gruber, Division of Pediatric Infectious Disease, Dept. of Pediatrics, Vanderbilt University School of Medicine, D-7235 Medical Center N., Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hinson, Hattie P" sort="Hinson, Hattie P" uniqKey="Hinson H" first="Hattie P." last="Hinson">Hattie P. Hinson</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Holland, Kathy L" sort="Holland, Kathy L" uniqKey="Holland K" first="Kathy L." last="Holland">Kathy L. Holland</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Thompson, Juliette M" sort="Thompson, Juliette M" uniqKey="Thompson J" first="Juliette M." last="Thompson">Juliette M. Thompson</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Reed, George W" sort="Reed, George W" uniqKey="Reed G" first="George W." last="Reed">George W. Reed</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Journal of Infectious Diseases</title>
<title level="j" type="abbrev">J Infect Dis.</title>
<idno type="ISSN">0022-1899</idno>
<idno type="eISSN">1537-6613</idno>
<imprint>
<publisher>The University of Chicago Press</publisher>
<date when="1993-11">1993</date>
<biblScope unit="vol">168</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="1282">1282</biblScope>
<biblScope unit="page" to="1285">1285</biblScope>
</imprint>
<idno type="ISSN">0022-1899</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0022-1899</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Healthy adult subjects (n = 198) were randomized to receive bivalent cold-adapted (ca) influenza A vaccine containing 107.4TCID50each of A/Kawasaki/9/86 (H1N1) and A/Los Angeles/2/87 (H3N2) by either nose drops (ND) or large-particle aerosol (LPA). All subjects had received monovalent inactivated influenza Bvaccine intramuscularly in the previous year. Ninety percent of LPA recipients and 82% of ND recipients preferred intranasal administration to their previous experience with intramuscular vaccine. Twenty-six (27%) of 98 LPA recipients and 47 (49%) of97 ND recipients reported swallowing vaccine (P = .008). Fever was observed uncommonly (⩾5%), and incidence of respiratory symptoms was comparable between groups. Fourfold or greater hemagglutination antibody response to at least one of the influenza A vaccine viruses was significantly more frequent after LPA (64%) than ND vaccination (43%; P = .005). LPA administration of ca influenza to the nasopharynx was well tolerated, safe, and more immunogenic than ND delivery.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Tennessee</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Tennessee">
<name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name>
</region>
<name sortKey="Gruber, William C" sort="Gruber, William C" uniqKey="Gruber W" first="William C." last="Gruber">William C. Gruber</name>
<name sortKey="Hinson, Hattie P" sort="Hinson, Hattie P" uniqKey="Hinson H" first="Hattie P." last="Hinson">Hattie P. Hinson</name>
<name sortKey="Holland, Kathy L" sort="Holland, Kathy L" uniqKey="Holland K" first="Kathy L." last="Holland">Kathy L. Holland</name>
<name sortKey="Reed, George W" sort="Reed, George W" uniqKey="Reed G" first="George W." last="Reed">George W. Reed</name>
<name sortKey="Thompson, Juliette M" sort="Thompson, Juliette M" uniqKey="Thompson J" first="Juliette M." last="Thompson">Juliette M. Thompson</name>
<name sortKey="Wright, Peter F" sort="Wright, Peter F" uniqKey="Wright P" first="Peter F." last="Wright">Peter F. Wright</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E88 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001E88 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FF07394531F4CCCA10E767C1D250500F18EEB6B6
   |texte=   Comparative Trial of Large-Particle Aerosol and Nose Drop Administration of Live Attenuated Influenza Vaccines
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021